Quest Diagnostics
879 hedge funds and large institutions have $15.2B invested in Quest Diagnostics in 2022 Q4 according to their latest regulatory filings, with 136 funds opening new positions, 277 increasing their positions, 309 reducing their positions, and 50 closing their positions.
172% more first-time investments, than exits
New positions opened: 136 | Existing positions closed: 50
79% more call options, than puts
Call options by funds: $143M | Put options by funds: $80.1M
21% more capital invested
Capital invested by funds: $12.6B → $15.2B (+$2.6B)
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
9% more funds holding
Funds holding: 808 → 879 (+71)
1.55% less ownership
Funds ownership: 88.52% → 86.97% (-1.6%)
10% less repeat investments, than reductions
Existing positions increased: 277 | Existing positions reduced: 309
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$76.3M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$51.6M |
| 3 |
AAMU
AEGON Asset Management (UK)
Edinburgh,
United Kingdom
|
+$38.9M |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$37.1M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$36.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$209M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$200M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$99.1M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$58.3M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$57.3M |
DGX Hedge Fund Activity: Q4 2022 in Review
879 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q4 2022, worth a combined $15.2B — up 21% from $12.6B a quarter earlier.
Buyers outnumbered sellers: 136 funds opened new DGX positions and 50 closed out — a net gain of 86 holders — while 277 added to existing stakes and 309 trimmed.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $76.3M. The largest seller was Bank of America, cutting an estimated $209M.
- 879 institutional investors held Quest Diagnostics (DGX) as of Q4 2022, up from 808 in Q3 2022.
- Funds reported $15.2B of Quest Diagnostics stock for Q4 2022, up 21% quarter-over-quarter.
- 136 funds opened new Quest Diagnostics positions in Q4 2022 and 50 closed out, a net change of +86 holders.
- The largest Quest Diagnostics buyer in Q4 2022 was Point72 Asset Management, an estimated $76.3M added.
- The largest Quest Diagnostics seller in Q4 2022 was Bank of America, an estimated $209M sold.
Based on aggregated 13F filings for Q4 2022.